StonvexLoading…
StonvexStonvexStonvexCore line items from MHO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $920.71M | $4.42B | $3.27B | $2.14B |
Operating Income | $86.06M | $506.55M | $431.91M | $296.64M |
Net Income | $67.83M | $402.94M | $338.97M | $232.48M |
EPS (Diluted) | $2.55 | $14.74 | $12.32 | $8.40 |
Total Assets | $4.79B | $4.78B | $4.77B | $4.74B |
Total Liabilities | $1.60B | $1.61B | $1.62B | $1.66B |
Cash & Equivalents | $767.42M | $689.19M | $734.17M | $800.40M |
Free Cash Flow OCF − CapEx | $135.58M | $127.74M | $140.70M | $98.69M |
Shares Outstanding | 26.56M | 27.34M | 27.51M | 27.67M |